Glenn Muir Net Worth & Insider Trades
Glenn Muir G1 Therapeutics, Inc
What is Glenn Muir's Net Worth?
The current estimated net worth of G1 Therapeutics, Inc's Glenn Muir is estimated to be about $80.2M . Glenn Muir owns about 170,969 units of G1 Therapeutics, Inc common stock. In the last 6 years at G1 Therapeutics, Inc, Glenn Muir has sold an estimated value of $0 worth.
What is Glenn Muir's Past Insider Trading?
Glenn Muir's largest purchase order was 50,000 units , worth over $675K on November 19, 2020. In total, Glenn Muir has made about 9 transactions over 6 years of their time at G1 Therapeutics, Inc. Glenn Muir usually trades in June, with the busiest year in 2020 and 2017.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GLENN MUIR
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Glenn Muir's' Mailing Address?
- Mailing address is C/o Hologic, Inc. Bedford MA 01730 MA
G1 Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| John E. Bailey, Jr. | 2020 | - | $542,109 | - | $215,948 | $758,057 |
| Mark A. Velleca, M.D., Ph.D. | 2020 | $608,308 | $3,069,704 | $305,000 | $8,550 | $3,991,562 |
| Mark A. Velleca, M.D., Ph.D. | 2019 | $589,700 | $3,105,237 | $280,108 | $8,400 | $3,983,445 |
| Mark A. Velleca, M.D., Ph.D. | 2018 | $515,000 | $1,044,529 | $321,875 | $33,250 | $1,914,654 |
| Jennifer K. Moses | 2020 | $398,583 | $1,116,239 | $141,050 | $8,550 | $1,664,422 |
| Jennifer K. Moses | 2019 | $315,598 | $972,601 | $117,600 | $8,400 | $1,414,199 |
| Mark Avagliano | 2020 | $431,417 | $837,165 | $151,200 | $18,445 | $1,438,227 |
| Mark Avagliano | 2019 | $181,913 | $5,100,560 | $142,800 | $53,117 | $5,478,390 |
| Rajesh K. Malik, M.D. | 2020 | $424,000 | $836,733 | $148,750 | $8,550 | $1,418,033 |
| Rajesh K. Malik, M.D. | 2019 | $413,000 | $828,195 | $138,768 | $8,400 | $1,388,363 |
| Rajesh K. Malik, M.D. | 2018 | $400,000 | $696,968 | $169,400 | $8,250 | $1,274,618 |
| Soma Gupta | 2020 | $320,360 | $2,212,758 | $114,662 | $100,000 | $2,747,780 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1560241/000119312521136977/d122680ddef14a.htm
What are G1 Therapeutics, Inc's Past Insider Trades?
G1 Therapeutics, Inc's most recent insider trade came on August 10, 2023 by Mark Velleca who sold 60,000 units worth $119.97K . In the last 6 years, insiders at G1 Therapeutics, Inc have sold an estimated value of $69.83M and bought an estimated value of $25.78M worth of shares. Insider trading is most common in January and June, with the busiest year in 2018. The most active traders at the company are Rajesh Malik, Chief Medical Officer, Mark Velleca, and Jennifer Moses, CFO .
G1 Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||